Interaction of the central analgesic, tramadol, with the uptake and release of 5‐hydroxytryptamine in the rat brain in vitro
Authors:
Open Access
- 1 January 1992
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 105 (1) , 147-151
Abstract
Tramadol is a centrally acting analgesic with low opioid receptor affinity and therefore presumably other mechanisms of analgesic action. Tramadol inhibits noradrenaline uptake but since 5‐hydroxytryptamine (5‐HT) is also involved in the modulation of pain perception, we tested the effects of tramadol on 5‐HT uptake and release in vitro. Tramadol inhibited the uptake of [3H]‐5‐HT into purified rat frontal cortex synaptosomes with an IC50 of 3.1 μm. The (+)‐enantiomer was about four times more potent than the (−)‐enantiomer; the main metabolite of tramadol, O‐desmethyltramadol, was about ten times less potent. Rat frontal cortex slices were preincubated with [3H]‐5‐HT, then superfused and stimulated electrically. Tramadol facilitated the basal outflow of [3H]‐5‐HT, at concentrations greater than 1 μm, while the uptake inhibitor 5‐nitroquipazine enhanced both basal and stimulation‐evoked overflow. Effects of the (+)‐enantiomer were more potent than either the racemate, the (−)‐enantiomer or the principal metabolite. The effects of tramadol on the basal outflow of [3H]‐5‐HT were almost completely abolished when the superfusion medium contained a high concentration of the selective 5‐HT uptake blocker, 6‐nitroquipazine. The results provide evidence for an interaction of tramadol with the neuronal 5‐HT transporter. An intact uptake system is necessary for the enhancement of extraneuronal 5‐HT concentrations by tramadol indicating an intraneuronal site of action.Keywords
This publication has 28 references indexed in Scilit:
- Effect of chronic treatment with tricyclic antidepressants upon antinociception induced by intrathecal injection of morphine and monoaminesNeuropharmacology, 1988
- The stereoselectivity of serotonin uptake in brain tissue and blood platelets: The topography of the serotonin uptake areaNeuroscience & Biobehavioral Reviews, 1986
- 5-Hydroxytryptamine and antinociceptionNeuropharmacology, 1984
- Pharmacological antagonism of the antinociceptive effects of serotonin in the rat spinal cordEuropean Journal of Pharmacology, 1983
- Effect of prostaglandins D2, E2 and F2α on catecholamine release from slices of rat and rabbit brainEuropean Journal of Pharmacology, 1981
- Serotonin release is modulated by presynaptic autoreceptorsEuropean Journal of Pharmacology, 1979
- Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-Bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analoguesNeuropharmacology, 1977
- Is drug inhibition of dopamine uptake a misinterpretation of in vitro experiments?Nature, 1976
- (Z)‐Dimethylamino‐l‐(4‐bromophenyl)‐l‐(3‐pyridyl) propene (H 102/09), a New Selective Inhibitor of the Neuronal 5‐Hydroxytryptamine UptakeActa Pharmacologica et Toxicologica, 1976
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966